{
  "abstract": "Zelig Eshhar, PhD, Fellow of the Academy of Immuno-Oncology (FAIO), passed away on July 3, 2025, at the age of 84. His passing is deeply personal to all of us and for the entire field of cancer immunotherapy. Professor Eshhar was one of the foundational immunologists for the concept of treating diseases with chimeric antigen receptor (CAR) redirected T cells, a technology that became a breakthrough in the treatment of cancer. His work and that of those who followed underscores the power of the immune system to control cancer, autoimmune diseases and potentially other diseases, giving hope to numerous patients around the world.",
  "authors": [
    {
      "affiliations": [
        "Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy, Regensburg, Germany"
      ],
      "name": "Hinrich Abken"
    },
    {
      "affiliations": [
        "Department of Immunology, James P Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"
      ],
      "name": "James P Allison"
    },
    {
      "affiliations": [
        "Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA"
      ],
      "name": "Renier Brentjens"
    },
    {
      "affiliations": [
        "Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"
      ],
      "name": "Carl H June"
    },
    {
      "affiliations": [
        "Hillman Cancer Center, Departments of Surgery, Immunology, and Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"
      ],
      "name": "Michael T Lotze"
    },
    {
      "affiliations": [
        "Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA"
      ],
      "name": "Crystal Mackall"
    },
    {
      "affiliations": [
        "Dana-Farber Cancer Institute, Boston, Massachusetts, USA",
        "Boston Children’s Hospital, Boston, Massachusetts, USA"
      ],
      "name": "Robbie G Majzner"
    },
    {
      "affiliations": [
        "Surgery Branch, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA"
      ],
      "name": "Steven A Rosenberg"
    },
    {
      "affiliations": [
        "Columbia Institute for Cell Engineering and Therapy, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA"
      ],
      "name": "Michel Sadelain"
    },
    {
      "affiliations": [
        "Division of Transplant and Cellular Therapies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA",
        "Parker Institute for Cancer Immunotherapy, San Francisco, California, USA"
      ],
      "name": "Eric Smith"
    },
    {
      "affiliations": [
        "Massachusetts General Hospital, Boston, Massachusetts, USA",
        "Harvard Medical School, Boston, Massachusetts, USA"
      ],
      "name": "Marcela V Maus, MD,"
    }
  ],
  "title": "Zelig Eshhar (1941–2025): a tribute for a life for immunotherapy",
  "uid": "c46fbc2d-9e6d-5d61-96ce-5ad776dda424"
}